Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalized medicine for glioblastoma: current challenges and future opportunities.

Current molecular medicine - 1 Mar 2013

Zhu J-J, Wong E T

Abstract excerpt

The failure to control glioblastoma progression is a major challenge for neuro-oncologists. Emerging data indicate that genetic and epigenetic heterogeneities within tumor cells play a dominant role in the development of resistant disease. These heterogeneities develop because driver mutations enable the proliferation of certain clones of transformed cells within the tumor microenvironment while pre-existing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Erlotinib Hydrochloride
Share to Glioblastoma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to MicroRNAs

Share to Precision Medicine

Share to Quinazolines

Share to Tumor Microenvironment

Source

Identifiers

PMID: 23331008

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalized medicine for glioblastoma: current challenges and future opportunities.PMID 23331008Read ↗

Personalized Medicine for GliomasSemantic proximity Read ↗

One size should not fit all: advancing toward personalized glioblastoma therapy.Semantic proximity Read ↗

Toward precision medicine in glioblastoma: the promise and the challenges.Semantic proximity Read ↗

EGFR heterogeneity and implications for therapeutic intervention in glioblastoma.Semantic proximity Read ↗

Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future DirectionsSemantic proximity Read ↗

The challenges associated with molecular targeted therapies for glioblastoma.Semantic proximity Read ↗

Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in GlioblastomaSemantic proximity Read ↗

Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment OpportunitiesSemantic proximity Read ↗

Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools.Semantic proximity Read ↗

Using the molecular classification of glioblastoma to inform personalized treatment.Semantic proximity Read ↗

Functional Precision Oncology: The Next Frontier to Improve Glioblastoma Outcome?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.